Company intelligence / Profile preview
Hybio Pharmaceutical
Shenzhen, Guangdong, Chinahybio.com.cn ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
01
Overview
Hybio is one of China’s largest manufacturers of therapeutic peptides with over 30 APIs in its portfolio. The company supplies both active pharmaceutical ingredients and finished dosage forms globally. Its products include generics such as liraglutide and semaglutide for diabetes/obesity as well as custom synthesis/CDMO services. It holds more than 410 patents and has received multiple international GMP certifications. Clinical results are not directly published by the company since it primarily produces generics or acts as a CDMO partner rather than running proprietary clinical trials.
- Therapeutic areas
- Metabolic DisordersEndocrinologyGastroenterologyWomen's Health
- Modalities
- PeptidesSmall molecule (limited, mainly peptide-focused)Oligonucleotide (CDMO services for oligonucleotides)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Supplies APIs to over “200+ pharma companies” worldwide; specific partners not named publicly but includes global pharma customers via CDMO/CRO relationships
Beyond the preview
Go deeper on Hybio Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hybio Pharmaceutical.